glp-1 anorexia Receptor Agonists and Eating Disorders — Cause for Concern Glucagon-Like Peptide-1 (GLP-1) in the

Within that context, glucagon receptor activation may contribute beneficial effects on energy expenditure, fatty acid oxidation, and hepatic lipid metabolism

Medications like Ozempic, Wegovy, and Mounjaro are now widely used in medical practices

The Four Key Reasons Healthcare Providers Recommend Stopping Reason #1: Animal studies raised red flags In pregnant rats and rabbits given GLP-1 medications, researchers observed increased pregnancy loss rates at high doses, skeletal abnormalities in some offspring, reduced fetal growth and birth weight, and developmental delays in some cases

Lynch L, Hogan AE, Duquette D, Lester C, Banks A, LeClair K, et al